Industry-Led Access-To-Medicines Initiatives In Low- And Middle-Income Countries: Strategies And Evidence-Reference-Cited by-同舟云学术

Industry-Led Access-To-Medicines Initiatives In Low- And Middle-Income Countries: Strategies And Evidence

Published:2017-04 Issue:4 Volume:36 Page:706-713
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Rockers Peter C.¹,Wirtz Veronika J.²,Umeh Chukwuemeka A.³,Swamy Preethi M.⁴,Laing Richard O.⁵

Affiliation:

1. Peter C. Rockers is an assistant professor of global health in the Department of Global Health at the Boston University School of Public Health, in Massachusetts.

2. Veronika J. Wirtz ( ) is an associate professor in the Department of Global Health and Center for Global Health and Development, Boston University School of Public Health.

3. Chukwuemeka A. Umeh is the director and principal research scientist at Lois & Bryant LLC, in Winchester, California. He was a research assistant in the Department of Global Health, Boston University School of Public Health, at the time this work was completed.

4. Preethi M. Swamy was a research assistant at the Boston University School of Medicine at the time this work was completed.

5. Richard O. Laing is a professor of international health in the Department of Global Health at the Boston University School of Public Health.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference12 articles.

1. Big Pharma and Social Responsibility — The Access to Medicine Index

2. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

3. Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal

4. Child mortality patterns in rural Tanzania: an observational study on the impact of malaria control interventions

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profits First, Health Second: The Pharmaceutical Industry and the Global South Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap";International Journal of Health Policy and Management;2024-05-18

2. Unequal Distribution of Innovation Efforts for Neglected Tropical Diseases: The Role of Funding Evaluation Criteria;Health;2024

3. Analysis of the Professional Aspects of Medical Drugs Industry in the Republic of Serbia in Times of COVID-19 Pandemic;Sustainability;2023-05-25

4. Availability and affordability of essential medicines and diagnostic tests for diabetes mellitus in Africa;Tropical Medicine & International Health;2022-10-18

5. Digital Health Technologies Applied by the Pharmaceutical Industry to Improve Access to Noncommunicable Disease Care in Low- and Middle-Income Countries;Global Health: Science and Practice;2022-09-26